1.

Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
The invention provides a method for preventing or treating male erectile dysfunction or female sexual arousal disorder by administering an effective amount of one or more factors from a group of factors including vascular endothelial growth factor, brain-derived neurotrophic factor, basic fibroblast growth factor, neurotrophin-3, neurotrophin-4, or angiopoietin-1. Click here for ED Doc. No. 20090099070

2.

Mechanical impotence treatment apparatus
A male sexual impotence treatment apparatus includes an adjustable non-inflatable restriction device implanted in a male impotent patient. The restriction device directly engages a portion of the normal penile tissue of the patient, such as both of the corpora cavernosa as a single unit or one or more of the exit veins from the penis, to affect the blood flow leaving the penis. Click here for ED Doc. No. 20090054725

3.

Method and apparatus for improving circulation and treating erectile dysfunction
A method, system, and apparatus for treating erectile dysfunction by using controlled intermittent pressure cycles in synchronization with the heart beat. Click here for ED Doc. No. 20090048481

4.

Oral fast dissolving films for erectile dysfunction bioactive agents
A novel edible polymer-based film dosage form manufactured using natural, synthetic, semisynthetic, pharmaceutically acceptable polymers addressing the issues of swallowing difficulties (Dysphagia and Dynaphagia), of tablet or capsule dosage forms and handling and storage difficulties associated with liquid dosage forms, that also includes materials such as emulsifying agents, suspending agents, buffering agents, effervescence agents, colorants, flavorants, sweeteners and specified amounts of bioactive agents, for erectile dysfunction. A flexible film dosage form containing sildenafil citrate, tadalafil or vardenafil is presented. Click here for ED Doc. No. 20090047330

5.

Methods and compositions for treatment of erectile dysfunction
A dosage chart for the treatment of achieving and maintaining male erectile response regardless of state of mind, occurrence of ejaculation or lack of sexual arousal of an object. The chart including a general, physical, and psychological conditions of the object; an age of the object; at least one pharmaceutical composition of one or more erection-producing agents; and a first corresponding dosage of the pharmaceutical composition to the age group and the general, physical, and psychological conditions of the object. Click here for ED Doc. No. 20090035221

6.

Extract of Ogalpi, erectile dysfunction fanning healthy food and erectile dysfunction treating agent containing the same
The present invention relates to an alcohol extract of ogalpi, erectile dysfunction improving health food and a treating agent containing the same, more precisely, an alcohol extract of ogalpi having an effect of improving erectile dysfunction, erectile dysfunction improving health food and an erectile dysfunction treating agent containing the same. Click here for ED Doc. No. 20090022822

7.

Methods for the treatment of erectile dysfunction using fispemifene
A method of treatment of erectile dysfunction (ED) includes the step of administering fispemifene to a subject in need thereof in an amount effective to raise the subject's testosterone level. Fispemifene may be used in combination with a PDE-5 inhibitor in individuals who have failed to respond sufficiently to conventional ED treatment. Click here for ED Doc. No. 20080312239

8.

System and method for treating erectile dysfunction
A treatment for male erectile dysfunction including separately storing a lyophilized composition of vasoactive agents and a carrier gel, mixing said lyophilized composition of vasoactive agents and said carrier gel creating a homogeneous mixture and applying said homogeneous mixture to the meatus of the glans penis. Click here for ED Doc. No. 20080287879

9.

Constriction device for male organ to obviate erectile dysfunction
A constriction device for the male sex organ of a user including: a substantially portable base; at least two bands, each including of an elastic central ring tightly adjustable onto said base; each elastic central ring tightly encircling male organ upon releasing the corresponding band from base, thereby substantially avoiding back-flow of blood out of the male organ and therefore improving penile erection. Click here for ED Doc. No. 20080262291

10.

Treatment of comorbid premature ejaculation and erectile dysfunction
The invention provides a method of treating comorbid premature ejaculation and erectile dysfunction. In particular, the method includes administering an effective amount of a tramadol material and an effective amount of a phosphodiesterase inhibitor. Click here for ED Doc. No. 20080262094

11.

Implantable peristaltic pump to treat erectile dysfunction
A method is provided for controlling blood flow through a blood vessel of a subject. The method includes implanting a pump outside of the blood vessel and placing within the blood vessel an expansion element that is capable of expanding the blood vessel subsequent to compression of the blood vessel by the pump. Click here for ED Doc. No. 20080234536

12.

Loadable polymeric particles for therapeutic use in erectile dysfunction and methods of preparing and using the same
Particles are provided for use in restorative procedures to treat erectile dysfunction. The particles include poly[bis(trifluoroethoxy)phosphazene] and/or derivatives thereof which may be present throughout the particles or within an outer coating of the particles. The particles may also include a core having a hydrogel formed from an acrylic-based polymer. Click here for ED Doc. No. 20080226723

13.

System and method for correcting erectile dysfunction
The invention is a generally bullet-shaped bulb having a proximal opening that transitions into a penile expansion chamber through a necked-down neck/seal section. The penile expansion chamber is a dual-purpose section activated by a user's hands to create a soft vacuum which draws the penis into the chamber and retains it. Click here for ED Doc. No. 20080146870

14.

Formulations useful in the treatment of male and female impotence
Pharmaceutical compositions containing: extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia in the weight ratio of 1.5-3.5:1-2:0.1-0.4 respectively; and optionally arginine or a physiologically equivalent ester, salt or precursor thereof. The compositions are useful in the treatment of male and female sexual dysfunctions. Click here for ED Doc. No. 20080145458

15.

Methods and compositions for treating erectile dysfunction
Methods are provided for increasing libido and/or treating erectile dysfunction in a man. The methods include the administration of a formulation testosterone alone, another fast-acting drug to treat erectile dysfunction or a combination of the testosterone and the other drug where at least one is delivered by aerosolization. Click here for ED Doc. No. 20080095718

16.

Use of acetyl L-carnitine in combination with propionyl L-carnitine and sildenafil for the treatment of erectile dysfunction
The use of acetyl L-carnitine in combination with propionyl L-carnitine and sildenafil is described for the preparation of a medicament and/or dietetic product for the treatment of erectile dysfunction secondary to all those conditions in which there is distress or iatrogenic damage of the lesser pelvis within which the neurovascular bundles of the penis run. Click here for ED Doc. No. 20080090906

17.

Methods and compositions for treating erectile dysfunction
The invention relates to inhalable formulations of testosterone with or without a fast-acting erectile dysfunction drug. Click here for ED Doc. No. 20080008661

18.

Method of diagnosing and treating erectile dysfunction
A method of diagnosing and treating a patient having erectile dysfunction by placement of a stent or paving material within a stenosed region of a pelvic vessel. The diagnosing of the patient's condition includes determining if a treatable stenosis exists within a pelvic vessel and if proper blood flow is otherwise occurring within the penile arteries. Click here for ED Doc. No. 20070283969

19.

Use of stellate ganglion block for the treatment of erectile dysfunction
The present invention is directed to a method for the treatment of a patient suffering from sexual dysfunction and other symptoms including the step of administering a stellate ganglion block to the patient to alleviate the symptoms. The stellate ganglion block may be followed by a sympathectomy to provide permanent relief. Click here for ED Doc. No. 20070250034

20.

Method and apparatus for relieving erectile dysfunction
A restrictor for relieving the symptoms of erectile dysfunction by applying pressure to the corpora cavemosa. The restrictor includes a visual gauge for signaling a purchaser of adequate fit and/or potential overuse. Click here for ED Doc. No. 20070238919

21.

Use of derivatives of 2, 5-dihydroxyb enzene-sulphonic acids in the elaboration of a medicinal product to enhance the effect of other drugs used for the treatment of erectile dysfunction
The present invention refers to the use of derivatives of 2,5-dihidroxybenzenosulphonic acids of general formula (I), to develop medicinal products of therapeutic value to enhance the effects of phosphodiesterase-5 including sildenaphyl, vardenaphyl and IC-351, of apomorphine, of nitric oxide donors including amyl nitrate, nitroglycerine, nitroprussiate, nitrosothioles and nicorandyl, of the compounds that increase the level of cyclic GMP in the penile tissue and of other compounds used to facilitate penile erection in man. Click here for ED Doc. No. 20070197543

22.

Progesterone/testosterone cream for erectile dysfunction
A consistent pattern of hormonal abnormalities in patients with erectile dysfunction was found. The study group included men from age 21 to 88 years old. By helping to correct the hormonal imbalance of progesterone and testosterone towards normal values, most of the men in the study were able to obtain normal erectile function. By using a progesterone/testosterone cream, the hormonal imbalance commonly found in men with erectile dysfunction was corrected. Click here for ED Doc. No. 20070167418

23.

Kit, system and method to treat erectile dysfunction
Embodiments of the present invention advantageously provide kits, systems, and methods for treating a patient's erectile dysfunction. An embodiment of a kit, for example, includes a pressure pump, a plurality of elongated vacuum chambers, and a plurality of penile tension devices positioned in a container. Click here for ED Doc. No. 20070129600

24.

Use of an alkanoyl l-carnitine for the treatment of the erectile dysfunction
Erectile dysfunction is treated with a combination of propionyl L-carnitine in combination with sildenafil, apomorphine prostaglandin E1, pentolamine and papaverine. Click here for ED Doc. No. 20070117762

25.

Male impotence prosthesis apparatus with wireless energy supply
A male impotence prosthesis apparatus includes an operable penile prosthesis implanted in an impotent patient's corpus cavernosum to provide flaccid or erect states of the patient's penis. An energy transmission device for wireless transmission of energy from outside the patient's body to inside the patient's body is provided for use in connection with the operation of the penile prosthesis. Click here for ED Doc. No. 20070015959

26.

Herbal composition and method of use for promoting erections and treating erectile dysfunction in men
The methods include administering a therapeutically effective composition of matter including the following herbal and other components: Herba cynomorii, Rhizhomnas atractylodis macrocephalae, Radix rehmannia glutinosea longui, Herba epimedii, Fructus lycii, Fructus schisandrae chinensis, Radix poloygoni multiflor, Cortex cinnamonia cassiae, Fructus amoni, and Radix ginseng. The components of the invention interact synergistically once consumed to remedy or prevent erectile dysfunction when taken as prescribed. Click here for ED Doc. No. 20060269623

27.

Delivery of erectile dysfunction drugs through an inhalation route
The present invention relates to the delivery of erectile dysfunction drugs through an inhalation route. Specifically, it relates to aerosols containing erectile dysfunction drugs that are used in inhalation therapy. Click here for ED Doc. No. 20060251588

28.

Method for treating erectile dysfunction and increasing libido in men
The present invention relates to a transdermal hydroalcoholic testosterone gel formulation that overcomes the problems associated with other testosterone delivery mechanisms by providing, among other things, a desirable pharmacokinetic hormone profile with little or no skin irritation. Click here for ED Doc. No. 20060211664

29.

Apparatus for patients of erectile dysfunction
The invention provides an apparatus for patients of erectile dysfunction, which is mounted to a flaccid or semi-flaccid penis to place it in an erect state and enables the user to get through sexual intercourse as is substantially the case with a sound man. Click here for ED Doc. No. 20060189949

30.

Implantable device and method for managing erectile dysfunction
An implantable device and method for managing a patient's erectile dysfunction is adapted to electrically stimulate the neurovascular bundle upon selective activation by the patient. Click here for ED Doc. No. 20060183970

31.

Medicinal agent and method for curing erectile dysfunction
A medicament based on antibodies contains an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to endothelial nitric oxide synthase (NO synthase), prepared according to the homeopathic technology is provided for the treatment of erectile dysfunction and vegetative disturbances of male climax such as premature ejaculation or delayed ejaculation disorders. Click here for ED Doc. No. 20060165697

32.

Careful impotence treatment apparatus
A male sexual impotence treatment apparatus includes an elongate adjustable constriction member extending in a loop around a male patient's penile tissue or the prolongation thereof. An adjustment device adjusts the longitudinal extension of the constriction member in the loop to temporarily constrict the penile tissue or the prolongation thereof to restrict the penile exit blood flow to achieve erection. Click here for ED Doc. No. 20060149125

33.

Electrically operable impotence treatment apparatus
A male sexual impotence treatment apparatus includes a constriction device implanted in a male patient, who suffers from sexual impotence, and engaging the patient's penile tissue or the prolongation thereof, and an electrically powered operation device, which is integrated with the constriction device and adapted to operate the latter to temporarily constrict the penile tissue or the prolongation thereof to restrict the penile exit blood flow to achieve erection. Click here for ED Doc. No. 20060149124

34.

Combination effective for the treatment of impotence
This invention relates to the treatment of erectile dysfunction with a combination of a compound selected from .alpha.-adrenergic receptor antagonists, and a compound selected from agents which elevate cGMP levels. Click here for ED Doc. No. 20060142282

35.

Impotence treatment apparatus with connection device
Provided is a male sexual impotence treatment apparatus including a constriction device implanted in an impotent male patient and engaging the patient's penile tissue. The constriction device includes an elongate adjustable constriction member extending in a loop around the penile tissue or the prolongation thereof. Click here for ED Doc. No. 20060079733

36.

Method of treating impotence due to spinal cord injury
A class of cGMP PDE inhibitors, including sidenafil and pharmaceutically acceptable salts thereof, which can be used to treat sexual dysfunction in male and female animals, especially humans, with a spinal cord injury. The invention can be used to treat sexual dysfunction in male animals that exhibit essentially no residual penile function. Click here for ED Doc. No. 20060040935

37.

Methods for treating or preventing erectile dysfunction or urinary incontinence
The present invention relates to methods for treating or preventing erectile dysfunction or urinary incontinence, including administering to a subject in need thereof an effective amount of a compound of the invention. Click here for ED Doc. No. 20060019980

38.

Methods and systems for stimulation as a therapy for erectile dysfunction
Systems and methods for stimulating tissue affecting the penis to treat erectile dysfunction may include stimulation using at least one implantable system control unit (SCU). Click here for ED Doc. No. 20050240229

39.

Methods and systems for electrical and/or drug stimulation as a therapy for erectile dysfunction
Systems and methods for introducing one or more stimulating drugs and/or applying electrical stimulation to tissue affecting the penis to treat erectile dysfunction (for instance, following prostate surgery) uses at least one implantable system control unit (SCU) producing electrical pulses delivered via electrodes and/or producing drug infusion pulses, wherein the stimulating drug(s) are delivered via one or more pumps and infusion outlets. Click here for ED Doc. No. 20050209652

40.

Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
The invention relates to a drug containing an aqueous formulation of Moxaverin and at least one water-miscible solubilizer. Click here for ED Doc. No. 20050208081

41.

Method for treating erectile dysfunction
Macrolide compound (I) is provided for treating or preventing erectile dysfunction, which is, for example, induced by or secondary to diseases, alcoholism, aging, arterial insufficiency, venous leakage, hormonal insufficiency, drug use, surgery, chemotherapy or radiation, particularly, for preventing or treating an erectile dysfunction of mammals. Click here for ED Doc. No. 20050182084

42.

Formulations useful in the treatment of male and female impotence
Pharmaceutical compositions containing: extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia in the weight ratio of 1.5-3.5:1-2:0.1-0.4 respectively; and optionally arginine or a physiologically equivalent ester, salt or precursor thereof are disclose for the treatment of male and female sexual dysfunctions. Click here for ED Doc. No. 20050175722

43.

Relieving symptoms of erectile dysfunction and attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
Sexual wellness or sexual fitness is enhanced over time by administrating on a daily basis a source of proanthocyanidins and a source of arginine. Both sources may be blended into a composition or taken separately from a kit. The source of arginine may be a salt or peptide of L-arginine and aspartic acid such as arginine aspartate. The proanthocyanidins stimulate an endothelial NO-synthase enzyme, which serves as a catalyst for synthesis of the nitric oxide from a substration that is the source of the arginine. Click here for ED Doc. No. 20050171030

44.

Compounds for the treatment of male erectile dysfunction
This invention describes compounds of formula (I) which are modulators of potassium channels and are useful for treating conditions affected by abnormal potassium channel activity including erectile dysfunction and irritable bowel syndrome. Click here for ED Doc. No. 20050124611

45.

Use of alkanoyl l-carnitine for the treatment of erectile dysfunction
The use of an alkanoyl L-carnitine for preparing a medicament for treating the erectile dysfunction is described. Click here for ED Doc. No. 20050080018

46.

Male sexual impotence treatment apparatus
A male sexual impotence treatment apparatus includes an adjustable restriction device implanted in an impotent patient and engaging the corpora cavernosa or crura or the prolongation thereof. An implanted adjustment device is adapted to adjust the restriction device to temporarily contract the corpora cavernosa, in order to restrict the blood flow leaving the penis when the patient desires to achieve erection. An implanted powered hydraulic operation device operates the adjustment device. Click here for ED Doc. No. 20030135089

47.

Prostaglandin compositions and methods of treatment for male erectile dysfunction
The methods include the step of placing within the fossa navicularis of the patient an effective erection-inducing amount of a vasoactive prostaglandin composition of a semi-solid consistency. The composition includes a vasoactive prostaglandin, a penetration enhancer, a shear-thinning polysaccharide, a lipophilic compound, and an acidic buffer system. Click here for ED Doc. No. 20030134903

48.

Transmucosal phosphodiesterase inhibitors for the treatment of erectile dysfunction
A pharmaceutical formulation is provided for treating erectile dysfunction in a mammalian male individual. The pharmaceutical formulation includes a phosphodiesterase inhibitor or a pharmaceutically acceptable salt, ester, amide or derivative thereof, that is administered transmucosally within the context of an effective dosing regimen. Click here for ED Doc. No. 20030134861

49.

Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
This invention provides a method of increasing or maintaining the blood supply in the penis of a male subject which includes administering to the subject an amount of vascular endothelial growth factor effective to increase or maintain the blood supply in the subject's penis. This invention provides a method of treating erectile dysfunction in a subject which includes administering to the subject an effective amount of vascular endothelial growth factor (VEGF). Click here for ED Doc. No. 20030124094

50.

Non-invasive, quantitative somatosensory method for the evaluation of erectile dysfunction
A non-invasive quantitative somatosensory method is provided for the neurological evaluation of erectile dysfunctions and involves the applications to the glans penis of different temperatures in increments of about 1.degree. C. until the patient can correctly identify which temperature starting at an ambient temperature was warmer for at least two consecutive times. Click here for ED Doc. No. 20030105413

51.

Phthalazine compounds and therapeutic agents for erectile dysfunction
The invention provides phthalazine compounds as prophylactic and therapeutic agents for male erectile dysfunction, and prophylactic and therapeutic agents for female sexual dysfunction or dysmenorrhea. Click here for ED Doc. No. 20030105074

52.

Apomorphine-containing dosage form for ameliorating male erectile dysfunction
Impotence can be ameliorated without substantial undesirable side effects by nasal administration of apomorphine, optionally with an antiemetic agent present in an amount sufficient to substantially reduce nausea symptoms that may be associated with the use of apomorphine. Click here for ED Doc. No. 20030073715

53.

Individualization of therapy with erectile dysfunction agents
The invention relates to the individualization of therapy on the basis of a phenotypic profile of an individual. More specifically, the present invention relates to the use of metabolic phenotyping for the individualization of treatment with ED agents. Click here for ED Doc. No. 20030073133

54.

Medicine containing yohimbine and arginine for treating erectile dysfunction
The invention concerns the use in combination of yohimbine and arginine as active ingredients for preparing a medicine for treating erectile dysfunction. The combination has a marked synergistic effect. Click here for ED Doc. No. 20020155136

55.

Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis
The invention is of a topical medicament and associated methodology for use thereof, through the use of which fibrosis of the elastic tissues and muscles of the human penis is reduced, thereby improving erectile function and/or reversing erectile dysfunction. One or more calcium channel blocker agents serve as the primary active ingredient of the present compositions. Click here for ED Doc. No. 20020151537